Kenvue Collabs with API for Recommendations on Oral Fluid Electrolytes

Kenvue Collabs with API for Recommendations on Oral Fluid Electrolytes

By, Admin 3 April 2024

Kenvue India collaborates with API to release recommendations on oral fluid electrolytes

Overview

Kenvue, the world’s largest pure-play consumer health company by revenue, released a whitepaper addressing challenges in oral fluid, electrolyte and energy management during transition care and discharge in hospitalized patients. The paper titled ""Role of Oral Fluid Electrolytes and Energy in Non-Diarrheal Illnesses in Hospitalized Patients” was released at API’s 79th annual conference, APICON 2024 under the guidance of API president Dr. Girish Mathur and Hon. general secretary Dr. Agam Vora. 

Consensus Based Approach

The recommendations capture the latest consensus from a team of Indian medical experts and aim to improve the approach to oral fluid, electrolyte, and energy (FEE) management in hospitalized patients suffering from non-diarrheal illnesses. 

Common Occurances

  • It has been found that there is a high occurrence of dehydration in hospitalized patients that is often overlooked. 
  • Patients also sometimes continue to experience fluid, electrolyte and energy deficits post discharge and need to re-admitted into hospitals. 
  • With hydration being an essential part of the recovery for hospitalized patients, assessing the level of dehydration and monitoring rehydration of patients is crucial.

Expert’s Panel

To better manage this necessity, Kenvue in association with the API convened a scientific advisory board meeting with eight multidisciplinary experts across India including a gastrointestinal surgeon, an internal medicine physician, a critical care physician, a diabetologist, and clinical dietician including Dr. B Ravinder Reddy, Dr. L Sreenivasa Murthy, Dr. Jyotirmoy Pal, Dr. Sanjith Saseedharan, Dr. Prachee Sathe, Dr. Anuj Maheshwari, Dr. Eileen Canday, and Babita Hazarika. The paper captures recommendations from Indian medical experts to identify, assess and appropriately address oral FEE deficits in hospitalized patients.

Guidelines Managing Dehydration

  • The recommendations provide guidelines to manage dehydration and prevent adverse effects of dehydration in hospitalized patients by including oral FEE as part of core treatment from day 1. 
  • The level of hydration among patients admitted is a parameter to be considered at the initial stages of admission and their hydration should be monitored along with the patient’s energy needs during de-escalation from IV to oral.
  • The recommendations also highlight the benefits of appropriate Ready-To-Drink (RTD) FEE formats with known concentrations of electrolytes and energy that act as adjuvants to facilitate faster recovery in the elderly and Diabetes patients as well as support patients with longstanding hospitalizations for cerebrovascular accidents, COPD, and pyrexia of unknown origin as well as for infectious non-diarrheal illnesses. 

Words from MD: Kenvue India

  • Manish Anandani, managing director, Kenvue India said, At Kenvue, we are committed to improving patient well-being and advancing healthcare standards in India. Developed under the guidance of API leadership, these consensus-based recommendations aim to address oral fluid, electrolyte, and energy deficits, a critical area often overlooked in hospitalized patients. 
  • These deficits can significantly impact recovery time and outcomes of patients. By implementing these recommendations, healthcare professionals can ensure optimal patient care and expedite the transition from the hospital to home. We believe this represents a significant step forward in improving patient care across India. 

Words from API

Dr Agam Vora, Hon. general secretary, Association of Physicians of India (API), said, “Dehydration and related deficits can significantly impede patient recovery and discharge, and these recommendations offer practical guidance for healthcare professionals to optimize patient care. The recommendations reflect the collective expertise of experienced Indian physicians, addressing a crucial issue often overlooked in hospitalized patients. We believe its implementation can positively impact patient outcomes and contribute to improved healthcare delivery across India.”

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!